Two Biotech Firms Pull Ahead in Race for $1,000 Human Genome Sequence

If you believe the press releases, the race to be first to achieve the $1,000 full human genome sequence is narrowing down to two primary contenders. One is Complete Genomics, Inc. of Mountain View, California, and the other is Pacific Biosciences (PacBio). Last fall, Complete Genomics, Inc. was profiled in The Dark Report. It has ambitiously declared that, by this spring, it will be ready to roll out a global commercial DNA sequencing service. The company intends to offer pharmaceutical firms...

Intel, Others Invest $100 Million in Speedy New DNA Sequencer

This morning it was announced that Intel Corp. (NASDAQ: INTC) and other investors will pump $100 million into a start-up company that says, by 2010, it will launch sales of a system capable of sequencing the human genome in 15 minutes. Pacific Biosciences of California, Inc. of Menlo Park, California, will receive $100 million in funding by a consortium of investors led by Intel Capital (the investment division of Intel Corp.) and Deerfield Capital Management, LLC, of Rosemont, Illinois. Other...
;